Remove 2016 Remove Clinical Trials Remove Conditions Remove Environment
article thumbnail

Pioneering Medical Cannabis Down Under

SpeedWeed

One of the reasons in fact she feels so at home in the cannabis industry is that after 20 years in the liquor business, she is no stranger to working in a highly regulated environment. I attended my first medical cannabis symposium in Sydney in 2016. What motivated you to enter the industry? day/night, temperature, humidity).

article thumbnail

South Australia: Is Adelaide About To See A Medical Cannabis Boom?

Cannabis Law Report

By early 2016, Australia’s federal parliament passed a bill that laid the groundwork for cannabis to be legally cultivated and manufactured for medicinal and scientific purposes here. In late 2016, Faenza was working with a team to identify potential Australian sites and scan the international market for the best production methods.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Study: CBD “Promising” Therapy for Cocaine Addiction

CannaMD

Note: No human studies were found (with the exception of one clinical trial that was ongoing and therefore not selected); all studies focused on animals (i.e., Conditioned place preference. We found that CBD impaired the reconsolidation of preference for the environment previously paired with both morphine and cocaine. [T]hese

Therapy 98
article thumbnail

UK Parliament Finds A Few Moments To Discuss Medical Cannabis & Emma Appleby Affair In Between Brexit Chaos

Cannabis Law Report

In November, UK law changed to allow clinicians to prescribe medical cannabis under limited conditions. Is he aware that in other jurisdictions a range of conditions qualify for treatment with cannabis oil and related products, including cancer, AIDS, muscular dystrophy, Crohn’s disease, epilepsy, Parkinson’s disease and arthritis?

article thumbnail

ElleVet Sciences Publishes Safety Study On CBD For Animals

Cannabis Law Report

Wakshlag is well-known in the veterinary medicine community as the first doctor to conduct an efficacy study in dogs in a clinical trial at Cornell using ElleVet CBD/CBDA on dogs with multi-joint discomfort. The clinical trial results confirmed more than 80% of dogs showed significant or dramatic improvement.

Safety 45
article thumbnail

First ethics at MAPS in question and now Australia’s Mind Medicine look to have some serious integrity issues too

Cannabis Law Report

Reporter Elise Worthington also investigates the dark side of this form of therapy where disturbing cases of abuse and malpractice are emerging in both clinical trials and the underground. The charity was eventually instructed to pull an advertisement for the study by the ethics committee that conditionally approved the trial.